Business Description
Abcam PLC
ISIN : US0003802040
Compare
Compare
Traded in other countries / regions
ABCM.USAA8C1.GermanyABC.UKABCM.Mexico IPO Date
2010-05-28Description
Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.36 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.3 | |||||
| Debt-to-EBITDA | 3.49 | |||||
| Interest Coverage | 1.08 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 5.89 | |||||
| Beneish M-Score | -1.84 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.9 | |||||
| 3-Year EBITDA Growth Rate | -22.7 | |||||
| 3-Year Book Growth Rate | 22.7 | |||||
| Future 3-5Y Total Revenue Growth Rate | 18.15 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.08 | |||||
| 9-Day RSI | 44.3 | |||||
| 14-Day RSI | 47.9 | |||||
| 6-1 Month Momentum % | 61.09 | |||||
| 12-1 Month Momentum % | 42.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.35 | |||||
| Quick Ratio | 1 | |||||
| Cash Ratio | 0.42 | |||||
| Days Inventory | 254.76 | |||||
| Days Sales Outstanding | 70.78 | |||||
| Days Payable | 177.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.8 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 75.88 | |||||
| Operating Margin % | 2.24 | |||||
| Net Margin % | 0.66 | |||||
| ROE % | 0.35 | |||||
| ROA % | 0.24 | |||||
| ROIC % | 5.73 | |||||
| ROC (Joel Greenblatt) % | 3.76 | |||||
| ROCE % | 1.06 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 1507 | |||||
| Forward PE Ratio | 32.68 | |||||
| PE Ratio without NRI | 1507 | |||||
| PS Ratio | 7.39 | |||||
| PB Ratio | 3.9 | |||||
| Price-to-Tangible-Book | 23.55 | |||||
| Price-to-Operating-Cash-Flow | 107.61 | |||||
| EV-to-EBIT | 437.87 | |||||
| EV-to-Forward-EBIT | 24.84 | |||||
| EV-to-EBITDA | 68.54 | |||||
| EV-to-Forward-EBITDA | 19.79 | |||||
| EV-to-Revenue | 11.36 | |||||
| EV-to-Forward-Revenue | 8.49 | |||||
| EV-to-FCF | -137.61 | |||||
| Price-to-Projected-FCF | 3.01 | |||||
| Price-to-Median-PS-Value | 0.74 | |||||
| Price-to-Graham-Number | 39.63 | |||||
| Earnings Yield (Greenblatt) % | 0.23 | |||||
| Forward Rate of Return (Yacktman) % | -8.94 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ABCM
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Abcam PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 471.548 | ||
| EPS (TTM) ($) | 0.015 | ||
| Beta | 0.86 | ||
| Volatility % | 58.03 | ||
| 14-Day RSI | 47.9 | ||
| 14-Day ATR ($) | 0.363928 | ||
| 20-Day SMA ($) | 22.7355 | ||
| 12-1 Month Momentum % | 42.68 | ||
| 52-Week Range ($) | 12.48 - 25.32 | ||
| Shares Outstanding (Mil) | 229.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Abcam PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Abcam PLC Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Abcam PLC Frequently Asked Questions
What is Abcam PLC(ABCM)'s stock price today?
The current price of ABCM is $22.60. The 52 week high of ABCM is $25.32 and 52 week low is $12.48.
When is next earnings date of Abcam PLC(ABCM)?
The next earnings date of Abcam PLC(ABCM) is 2024-03-20 Est..
Does Abcam PLC(ABCM) pay dividends? If so, how much?
Abcam PLC(ABCM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers